Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Cadranel

Showing results (311-320 of 329) with videos related to

Pageof 33
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 7, 2025
[Recommendations on the prevention and management of radiation-induced lung injury from the Association francophone pour les soins oncologiques de support and the Société française de radiothérapie oncologique]Olivier Cravéreau, Vincent Bourbonne, Loïg Vaugier, et al.
Nature Medicine|November 27, 2023
Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditisCharlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
Nature Medicine|January 3, 2024
Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditisCharlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
Nature Medicine|October 26, 2023
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditisCharlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
The European Respiratory Journal|May 25, 2023
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trialJulie Mankikian, Agnès Caille, Martine Reynaud-Gaubert, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 9, 2025
Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLCBaptiste Abbar, Karim Labreche, Jacques Cadranel, et al.
Annals of Internal Medicine|July 28, 2025
Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis : A Randomized Controlled TrialBenjamin Terrier, Grégory Pugnet, Claire de Moreuil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2021
Clinicopathologic Features and Response to Therapy of <i>NRG1</i> Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter RegistryAlexander Drilon, Michael Duruisseaux, Ji-Youn Han, et al.
The Journal of Experimental Medicine|March 10, 2026
The STING HAQ haplotype and clinical non-penetrance in COPA syndromeClémence David, Tifenn Wauquier, Alix de Becdelièvre, et al.
The European Respiratory Journal|April 4, 2024
High risk of lung cancer in surfactant-related gene variant carriersAlexandre Brudon, Marie Legendre, Arthur Mageau, et al.
Pageof 33

Showing results (311-320 of 329) with videos related to

Sort By:
Pageof 33
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 7, 2025
[Recommendations on the prevention and management of radiation-induced lung injury from the Association francophone pour les soins oncologiques de support and the Société française de radiothérapie oncologique]Olivier Cravéreau, Vincent Bourbonne, Loïg Vaugier, et al.
Nature Medicine|November 27, 2023
Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditisCharlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
Nature Medicine|January 3, 2024
Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditisCharlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
Nature Medicine|October 26, 2023
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditisCharlotte Fenioux, Baptiste Abbar, Samia Boussouar, et al.
The European Respiratory Journal|May 25, 2023
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trialJulie Mankikian, Agnès Caille, Martine Reynaud-Gaubert, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 9, 2025
Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLCBaptiste Abbar, Karim Labreche, Jacques Cadranel, et al.
Annals of Internal Medicine|July 28, 2025
Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis : A Randomized Controlled TrialBenjamin Terrier, Grégory Pugnet, Claire de Moreuil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2021
Clinicopathologic Features and Response to Therapy of <i>NRG1</i> Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter RegistryAlexander Drilon, Michael Duruisseaux, Ji-Youn Han, et al.
The Journal of Experimental Medicine|March 10, 2026
The STING HAQ haplotype and clinical non-penetrance in COPA syndromeClémence David, Tifenn Wauquier, Alix de Becdelièvre, et al.
The European Respiratory Journal|April 4, 2024
High risk of lung cancer in surfactant-related gene variant carriersAlexandre Brudon, Marie Legendre, Arthur Mageau, et al.
Pageof 33